ATYMUVE Trademark
ATYMUVE is a USPTO trademark filed by Dr. Reddy's Laboratories Limited. Status: Pending.
Prosecution Summary
Trademark Summary
The standard character mark ATYMUVE covers pharmaceutical and medicinal preparations for the treatment of rheumatoid arthritis, psoriatic arthritis, and pediatric idiopathic arthritis, and for the prophylaxis of acute graft-versus-host disease in International Class 005, along with domestic classes 006, 018, 044, 046, 051, and 052. It is owned by Dr. Reddy's Laboratories Limited, an Indian limited company based in Hyderabad, Telangana. A Notice of Allowance was issued on December 2, 2025, requiring the applicant to file a Statement of Use or extension request within six months; no other notable issues are present.
Recent Activity
Filed on January 14, 2025, under intent-to-use basis, the application received a non-final office action on June 24, 20
Trademark Facts
| Mark | ATYMUVE |
|---|---|
| Serial Number | 98959616 |
| Status | Pending |
| Filing Date | 2025-01-14 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Dr. Reddy's Laboratories Limited |
| Attorney of Record | Michael S. Hargis |
| Prosecution Events | 14 |
| Latest Event | NOAM on 2025-12-02 |
Goods & Services
Pharmaceutical and Medicinal Preparations